Inhibition of naphthalene cataract in rats by aldose reductase inhibitors

Current Eye Research

Volumn 15, Issue 4, 1996, Pages 423-432

  Lou, Marjorie F ^a,b   Xu, Guo Tong ^c   Zigler Jr , Samuel ^d   York Jr , Bill ^e  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH TEXAS   (United States)

^d NATIONAL EYE INSTITUTE   (United States)

^e ALCON RESEARCH LTD   (United States)

Author keywords

Aldose reductase inhibitor; Cataract; Naphthalene; Rat

Indexed keywords

2 FLUOROSPIRO[FLUORENE 9,4' IMIDAZOLIDINE] 2',5' DIONE; AL 04114; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; CYTOCHROME P450; DIHYDRODIOL DEHYDROGENASE; GALACTITOL; GALACTOSE; GLUTATHIONE; NAPHTHALENE; NAPHTHALENE DERIVATIVE; O METHOXYSPIRO(2,7 DIFLUOROFLUORENE 9,4 IMIDAZOLIDINE) 2,5 DIONE; SORBINIL; TOLRESTAT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CATARACT; CATARACTOGENESIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; ENZYME INHIBITION; MALE; METABOLISM; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029978072     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.3109/02713689608995833     Document Type: Article

References (26)

1. Adams, D. R. (1930) The nature of the ocular lesions produced experimentally by naphthalene. Br. J. Ophthalmol. 14, 49-60.
2. Pirie, A. (1968) Pathology in the eye of the naphthalene-fed rabbit. Exp. Eye Res. 7, 354-357.
3. Van Heyningen, R. and Pirie, A. (1967) The metabolism of naphthalene and its toxic effect on the eye. Biochem. J. 102, 842-852.
4. Koch, H. R. and Hockwin, O. (1976) Naphthalene cataracts in rats: Association of eye pigmentation and cataract development. Doc. Ophthalmol. 8, 293-303.
5. Van Heyningen R. (1979) Naphthalene cataracts in rats and rabbits: a resume. Exp. Eye Res. 28, 435-439.
6. Hockwin, O., Wegener, A., Sisk, D. R., Dohrmann, B. and Kruse, M. (1984-85) Efficacy of AL01576 in preventing naphthalene cataract in three rat strains. A slit-lamp and scheimpflug photographic study. Lens Research, 2, 321-335.
7. Iwata, S. and Maesato, T. (1988) Studies on the mercapturic acid pathway in the rabbit lens. Exp. Eye Res. 47, 479-488.
8. Lubek, B. M., Kubow, S., Baser, P. K. and Wells, P. G. (1989) Cataractogenicity and bioactivation of naphthalene derivatives in lens culture and in vivo. Lens Eye Toxicity Res. 6, 203-209.
9. Rathbun, W. B., Holleschau, A. M., Murray, D. L., Buchanan, A., Sawaguchi, S. and Tao, R. V. (1990) Glutathione synthesis and glutathione redox pathways in naphthalene cataract of the rat. Curr. Eye Res. 9, 45-53.
10. Tao, R. V., Takahashi, T. and Kador, P. F. (1991) Effect of aldose reductase inhibitor on naphthalene cataract formation in the rat. Invest. Ophthalmol. Vis. Sci. 32, 1630-1637.
11. Xu, G. T., Zigler, J. S. and Lou, M. F. (1992) The possible mechanism of naphthalene cataract in rat and its prevention by an aldose reductase inhibitor (AL01576). Exp. Eye Res. 54, 63-72.
12. Xu, G.-T., Zigler, J. S. and Lou, M. F. (1992) Establishment of a naphthalene cataract model in vitro. Exp. Eye Res. 54, 73-81.
13. Sato, S. (1993) Aldose reductase is the major protein associated with naphthalene dihydrodiol dehydrogenase activity in rat lens. Invest. Ophthalmol. Vis. Sci. 34, 3172-3178.
14. Kiss, A. D., Haggard, K., Veltman, J. D. and Zeigler, D. M. (1992) Oxidation of aldose reductase inhibitors AL04114 and AL03152 catalyzed by liver microsomes. Drug Metabolism and Disposition, 20, 948-953.
15. Lou, M. F., Dickerson, J. E., Jr., Garadi, R. and York, B. M., Jr. (1988) Glutathione Depletion in the lens of galactosemic and diabetic rats. Exp. Eye Res. 46, 517-530.
16. Simard-Duquesne, N., Greselin, E., Dubuc, J. and Dvornik, D. (1985) The effect of a new aldose reductase inhibitor (tolrestat) in galactosemic and diabetic rats. Metabolism, 34, 885-892.
17. Dvornik, D., Miller, J. and Kemper, C. (1986) Prevention by tolrestat of the biochemical and morphological changes in galactose-fed rats. Diabetes (Abstract) 35 (Suppl.), 215A.
18. Lou, M. F., Dickerson, J. E., Jr. and Garadi, R. (1990) The role of protein-thiol mixed disulfides in cataractogenesis. Exp. Eye Res. 50, 819-826.
19. Rees, J. R. and Pirie, A. (1967) Possible reactions of 1,2-naphthoquinone in the eye. Biochem. J. 102, 853-863.
20. Hara, A., Nakayama, T., Harada, T., Kanazu, T., Shinoda, M., Deyashiki, Y. and Sawada, H. (1991) Distribution and characterization of dihydrodiol dehydrogenases in mammalian ocular tissues. Biochem. J. 275, 113-119.
21. Ludvigson, M. A. and Sorenson, R. L. (1980) Immunohistochemical localization of aldose reductase II. Rat eye and kidney. Diabetes, 29, 450-459.
22. Akagi, Y., Tasaka, H., Terubayashi, H., Kador, P. F. and Kinoshita, J. H. (1988) Aldose reductase localization in rat sugar cataract. In Polyol Pathway and Its Role in Diabetic Complications (Eds. Sakamoto, N., Kinoshita, J. H., Kador, P. R. and Hotta, N.). Pp. 178-181. Elsevier Science.
23. Robison, W. G., Jr., Houlder, N. and Kinoshita, J. H. (1990) The role of lens epithelium in sugar cataract formation. Exp. Eye Res. 50, 641-646.
24. Robison, W. G., Jr., Laver, N. M. and Lou, M. F. (1995) The role of aldose reductase in diabetic retinopathy: prevention and intervention studies. In Progress in Retinal and Eye Research (Eds. Osborne, N. N. and Chader, G. J.). 14, Pp. 593-640. Oxford, Pergamon.
25. Wells, P. G., Wilson, B. and Lubek, B. M. (1989) In vivo murine studies on the biochemical mechanism of naphthalene cataractogenesis. Toxicol. Appl. Pharmacol. 99, 466-473.
26. Griffin, B. D. (1991) Acute systemic dose-response study of biochemical efficacy of AL04114 in lens, sciatic nerves, and retinas of streptozoticin-treated diabetic rats. Technical Report on file at Alcon Laboratories, Inc. Fort Worth, TX.